Style | Citing Format |
---|---|
MLA | Saadatieskandari N, et al.. "Phenylalanine and Indole Effects on the Pathogenicity of Human Lysozyme Amorphous Aggregates." Enzyme and Microbial Technology, vol. 158, no. , 2022, pp. -. |
APA | Saadatieskandari N, Navidpour L, Yaghmaei P, Ebrahimhabibi A (2022). Phenylalanine and Indole Effects on the Pathogenicity of Human Lysozyme Amorphous Aggregates. Enzyme and Microbial Technology, 158(), -. |
Chicago | Saadatieskandari N, Navidpour L, Yaghmaei P, Ebrahimhabibi A. "Phenylalanine and Indole Effects on the Pathogenicity of Human Lysozyme Amorphous Aggregates." Enzyme and Microbial Technology 158, no. (2022): -. |
Harvard | Saadatieskandari N et al. (2022) 'Phenylalanine and Indole Effects on the Pathogenicity of Human Lysozyme Amorphous Aggregates', Enzyme and Microbial Technology, 158(), pp. -. |
Vancouver | Saadatieskandari N, Navidpour L, Yaghmaei P, Ebrahimhabibi A. Phenylalanine and Indole Effects on the Pathogenicity of Human Lysozyme Amorphous Aggregates. Enzyme and Microbial Technology. 2022;158():-. |
BibTex | @article{ author = {Saadatieskandari N and Navidpour L and Yaghmaei P and Ebrahimhabibi A}, title = {Phenylalanine and Indole Effects on the Pathogenicity of Human Lysozyme Amorphous Aggregates}, journal = {Enzyme and Microbial Technology}, volume = {158}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Saadatieskandari N AU - Navidpour L AU - Yaghmaei P AU - Ebrahimhabibi A TI - Phenylalanine and Indole Effects on the Pathogenicity of Human Lysozyme Amorphous Aggregates JO - Enzyme and Microbial Technology VL - 158 IS - SP - EP - PY - 2022 ER - |